The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials.
about
Bipolar disorder and mechanisms of action of mood stabilizersLithium enhances remyelination of peripheral nervesEpigenetics in mood disordersConversion of psychological stress into cellular stress response: roles of the sigma-1 receptor in the processThe mood stabilizers valproic acid and lithium enhance mesenchymal stem cell migration via distinct mechanismsValproic acid induces functional heat-shock protein 70 via Class I histone deacetylase inhibition in cortical neurons: a potential role of Sp1 acetylationValproic acid induces astrocyte-dependent neurite outgrowth from cultured rat primary cortical neuron via modulation of tPA/PAI-1 activityNew therapeutic targets for mood disordersGABA A Receptors in the Dorsal Hippocampus are Involved in Sate-dependent Learning Induced by Lithium in Mice.Is glycogen synthase kinase-3 a central modulator in mood regulation?The extracellular signal-regulated kinase pathway contributes to the control of behavioral excitementReverse translational strategies for developing animal models of bipolar disorder.A systematic review of existing data on long-term lithium therapy: neuroprotective or neurotoxic?Chronic NMDA administration to rats increases brain pro-apoptotic factors while decreasing anti-Apoptotic factors and causes cell death.Beneficial effects of mood stabilizers lithium, valproate and lamotrigine in experimental stroke models.Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3).Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients.Altered levels of extracellular signal-regulated kinase signaling proteins in postmortem frontal cortex of individuals with mood disorders and schizophrenia.Protocol for a double-blind randomised placebo-controlled trial of lithium carbonate in patients with amyotrophic lateral sclerosis (LiCALS) [Eudract number: 2008-006891-31].Histone deacetylases and mood disorders: epigenetic programming in gene-environment interactionsEvidence of altered DNA integrity in the brain regions of suicidal victims of Bipolar DepressionLithium enhances survival and regrowth of spinal motoneurons after ventral root avulsion.Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2GSK3β-dependent inhibition of AMPK potentiates activation of neutrophils and macrophages and enhances severity of acute lung injury.Histone deacetylase inhibitors for treating a spectrum of diseases not related to cancerThe paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways.DISC1 regulates synaptic vesicle transport via a lithium-sensitive pathway.Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disordersNeuronal damage and protection in the pathophysiology and treatment of psychiatric illness: stress and depression.Combined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of Huntington's disease.Complementary roles for histone deacetylases 1, 2, and 3 in differentiation of pluripotent stem cells.Lithium prevents long-term neural and behavioral pathology induced by early alcohol exposureProgress in the Development of Small Molecule Therapeutics for the Treatment of Neuronal Ceroid Lipofuscinoses (NCLs).Lithium ions attenuate serum-deprivation-induced apoptosis in PC12 cells through regulation of the Akt/FoxO1 signaling pathways.Lithium rescues the impaired autophagy process in CbCln3(Δex7/8/Δex7/8) cerebellar cells and reduces neuronal vulnerability to cell death via IMPase inhibition.Protein kinase B/Akt modulates nephrotoxicant-induced necrosis in renal cells.Off label use of lithium in the treatment of Huntington's disease: A case series.Proteomic analysis of peripheral leukocytes in Alzheimer's disease patients treated with divalproex sodiumChronic administration of mood stabilizers upregulates BDNF and bcl-2 expression levels in rat frontal cortex.NR2B subunit of the NMDA glutamate receptor regulates appetite in the parabrachial nucleus
P2860
Q22252332-8ABD12DD-FD82-48A6-948B-EF03B916FE70Q24612558-F0BDFE94-C931-4615-8465-61B286D3347BQ24644659-D9E6DE45-D46F-4FC4-A6FD-C831CD5903ACQ27023681-0DFA4C46-AD48-4F43-87A5-31E316C8ED49Q28568768-AF6062DE-7A59-4A6E-BFAD-3A4D4C4AF8EEQ28572236-B30CBC23-C130-4ED9-9125-3ACB479C3FD3Q28581097-D70F8359-9862-4722-8B0B-72840BBDF401Q28743068-32326A83-AEF0-4996-BBB8-FBB884FA2DA5Q30445583-D9D1473E-1676-44E1-B0E7-D88920F0ED79Q30475816-BEE6476B-DBF0-432E-9527-64BB26C71F10Q30484058-C99ADBB8-9347-4AAB-8FC2-577AD00A599BQ30489800-38FDC5F4-AF53-48CF-B016-631CBCE7384EQ33284843-C0AA9A5D-E431-4E4A-939D-3479B4628CD5Q33507174-1A18C264-EB67-4ED8-8AC1-863DD3939B74Q33566724-61218E3A-24F4-4467-977D-EA25AC9FBFF7Q33636704-7AC0B8BF-C8F6-48E5-BE9C-C3154450DFA0Q33664124-0AF7C392-AE4B-4816-AE5C-8527EC514CDAQ33872654-64E5BA80-66B1-489D-80F2-625300DA8C98Q34026859-EDF99A22-060E-42D2-AC3B-ACA02FECCCBEQ34144718-1F87F2BE-8005-4AA1-AF11-8C0C08D64F0FQ34345211-9C36CC6D-6669-428B-8678-6FAA3ABAB1B1Q34485199-0598BDC8-2031-4E9C-A19E-18E1784F36DDQ34496410-1CA7B136-93E1-4911-98B0-E48766CA686DQ34519373-1DD5B676-B39F-4EE4-AA23-A2A3A786331FQ35016934-A6944016-B2E2-4467-AC64-47D0E7F4546FQ35103813-897C5598-7B92-496A-92A9-27DAC719D23EQ35164530-5C88C344-41E3-4A6B-9848-E4E58DF2144EQ35197096-F6E7311E-D87F-4932-9F0E-9D029363B634Q35237104-8259CEDB-85D1-4D7C-92EC-7C31B9D11BC3Q35356604-DB6ECF4E-B05C-4AB4-966B-43B5553BBA15Q35595888-90AF5F5B-9EC9-48BE-88E2-242D9C0A5CBBQ35803113-0C3E8DBB-562C-46FD-8DFA-A423FAF835CAQ35840603-40723AEC-5375-4977-813A-33A6871F4940Q35857649-2E456DED-F2B3-40D4-B967-0810F8D1FBD0Q35896710-C639567A-1AF9-4DE7-BE82-F1EE196CE89DQ35933401-FD057558-E2A9-4AAA-A180-9F4360B67170Q36615521-E6DC3090-707E-43E0-A830-5806F2F51FFEQ37052151-C8F79E59-5D56-4346-B4AD-BE9621D4DEEDQ37088689-1D80841F-7F78-4367-B72A-D862F9E39B5AQ37157389-06D2B26E-9EDF-464B-BB83-4A03EEC0C009
P2860
The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
The antiapoptotic actions of m ...... ms and therapeutic potentials.
@ast
The antiapoptotic actions of m ...... ms and therapeutic potentials.
@en
type
label
The antiapoptotic actions of m ...... ms and therapeutic potentials.
@ast
The antiapoptotic actions of m ...... ms and therapeutic potentials.
@en
prefLabel
The antiapoptotic actions of m ...... ms and therapeutic potentials.
@ast
The antiapoptotic actions of m ...... ms and therapeutic potentials.
@en
P356
P1476
The antiapoptotic actions of m ...... ms and therapeutic potentials.
@en
P2093
De-Maw Chuang
P304
P356
10.1196/ANNALS.1344.018
P407
P577
2005-08-01T00:00:00Z